Do analysts prefer CBT or IOSP?

Cabot presently has a consensus target price of $85.80, suggesting a potential downside of 2.27%. Given Cabot's stronger consensus rating and higher probable upside, equities analysts clearly believe Cabot is more favorable than Innospec. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Cabot 1 Sell rating(s) 4 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.14 Innospec 0 Sell rating(s) 2 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00

Which has better valuation & earnings, CBT or IOSP?

Cabot has higher revenue and earnings than Innospec. Cabot is trading at a lower price-to-earnings ratio than Innospec, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Cabot $3.71B 1.22 $331M $5.29 16.60 Innospec $1.78B 1.14 $116.60M $4.59 17.87

Is CBT or IOSP more profitable?

Cabot has a net margin of 7.97% compared to Innospec's net margin of 6.38%. Cabot's return on equity of 21.33% beat Innospec's return on equity. Company Net Margins Return on Equity Return on Assets Cabot 7.97% 21.33% 9.48% Innospec 6.38% 9.32% 6.79%

Does the media prefer CBT or IOSP?

In the previous week, Cabot had 2 more articles in the media than Innospec. MarketBeat recorded 4 mentions for Cabot and 2 mentions for Innospec. Cabot's average media sentiment score of 0.57 beat Innospec's score of 0.47 indicating that Cabot is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Cabot 0 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Innospec 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Which has better earnings & valuation, CBT or ASIX?

Cabot has higher revenue and earnings than AdvanSix. Cabot is trading at a lower price-to-earnings ratio than AdvanSix, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Cabot $3.71B 1.22 $331M $5.29 16.60 AdvanSix $1.52B 0.37 $49.29M $0.37 56.50

Is CBT or ASIX more profitable?

Cabot has a net margin of 7.97% compared to AdvanSix's net margin of 0.67%. Cabot's return on equity of 21.33% beat AdvanSix's return on equity. Company Net Margins Return on Equity Return on Assets Cabot 7.97% 21.33% 9.48% AdvanSix 0.67% 2.18% 1.05%

Does the media favor CBT or ASIX?

In the previous week, Cabot had 1 more articles in the media than AdvanSix. MarketBeat recorded 4 mentions for Cabot and 3 mentions for AdvanSix. AdvanSix's average media sentiment score of 0.75 beat Cabot's score of 0.57 indicating that AdvanSix is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Cabot 0 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive AdvanSix 1 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Which has preferable earnings and valuation, AVNT or CBT?

Cabot has higher revenue and earnings than Avient. Cabot is trading at a lower price-to-earnings ratio than Avient, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Avient $3.26B 1.00 $81.90M $1.72 20.70 Cabot $3.71B 1.22 $331M $5.29 16.60

Is AVNT or CBT more profitable?

Cabot has a net margin of 7.97% compared to Avient's net margin of 4.81%. Cabot's return on equity of 21.33% beat Avient's return on equity. Company Net Margins Return on Equity Return on Assets Avient 4.81% 11.11% 4.40% Cabot 7.97% 21.33% 9.48%

Does the media prefer AVNT or CBT?

In the previous week, Cabot had 1 more articles in the media than Avient. MarketBeat recorded 4 mentions for Cabot and 3 mentions for Avient. Avient's average media sentiment score of 0.78 beat Cabot's score of 0.57 indicating that Avient is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Avient 1 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Cabot 0 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Is CBT or CC more profitable?

Cabot has a net margin of 7.97% compared to Chemours' net margin of -6.82%. Chemours' return on equity of 52.49% beat Cabot's return on equity. Company Net Margins Return on Equity Return on Assets Cabot 7.97% 21.33% 9.48% Chemours -6.82% 52.49% 1.78%

Does the media prefer CBT or CC?

In the previous week, Cabot and Cabot both had 4 articles in the media. Chemours' average media sentiment score of 1.06 beat Cabot's score of 0.57 indicating that Chemours is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Cabot 0 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Chemours 3 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media prefer CBT or EMN?

In the previous week, Cabot had 2 more articles in the media than Eastman Chemical. MarketBeat recorded 4 mentions for Cabot and 2 mentions for Eastman Chemical. Cabot's average media sentiment score of 0.57 beat Eastman Chemical's score of 0.56 indicating that Cabot is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Cabot 0 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Eastman Chemical 1 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Cabot (CBT) Competitors

$87.79 +0.47 (+0.54%)

Closing price 03:59 PM Eastern

Extended Trading

$87.86 +0.06 (+0.07%)

As of 06:18 PM Eastern

Compare

CBT vs. IOSP, ASIX, AVNT, CC, and EMN

Should you buy Cabot stock or one of its competitors? MarketBeat compares Cabot with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Cabot include Innospec (IOSP), AdvanSix (ASIX), Avient (AVNT), Chemours (CC), and Eastman Chemical (EMN). These companies are all part of the "basic materials" sector.

How does Cabot compare to Innospec?

Cabot (NYSE:CBT) and Innospec (NASDAQ:IOSP) are both mid-cap basic materials companies, but which is the superior business? We will compare the two companies based on the strength of their earnings, dividends, risk, institutional ownership, media sentiment, valuation, profitability and analyst recommendations.

Cabot presently has a consensus target price of $85.80, suggesting a potential downside of 2.27%. Given Cabot's stronger consensus rating and higher probable upside, equities analysts clearly believe Cabot is more favorable than Innospec.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Cabot	1 Sell rating(s)	4 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.14
Innospec	0 Sell rating(s)	2 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00

Cabot has a net margin of 7.97% compared to Innospec's net margin of 6.38%. Cabot's return on equity of 21.33% beat Innospec's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Cabot	7.97%	21.33%	9.48%
Innospec	6.38%	9.32%	6.79%

93.2% of Cabot shares are held by institutional investors. Comparatively, 96.6% of Innospec shares are held by institutional investors. 3.1% of Cabot shares are held by company insiders. Comparatively, 1.5% of Innospec shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Cabot pays an annual dividend of $1.89 per share and has a dividend yield of 2.2%. Innospec pays an annual dividend of $1.84 per share and has a dividend yield of 2.2%. Cabot pays out 35.7% of its earnings in the form of a dividend. Innospec pays out 40.1% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Cabot has raised its dividend for 14 consecutive years and Innospec has raised its dividend for 11 consecutive years.

Cabot has higher revenue and earnings than Innospec. Cabot is trading at a lower price-to-earnings ratio than Innospec, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Cabot	$3.71B	1.22	$331M	$5.29	16.60
Innospec	$1.78B	1.14	$116.60M	$4.59	17.87

In the previous week, Cabot had 2 more articles in the media than Innospec. MarketBeat recorded 4 mentions for Cabot and 2 mentions for Innospec. Cabot's average media sentiment score of 0.57 beat Innospec's score of 0.47 indicating that Cabot is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Cabot	0 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Innospec	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Cabot has a beta of 0.83, indicating that its stock price is 17% less volatile than the broader market. Comparatively, Innospec has a beta of 0.93, indicating that its stock price is 7% less volatile than the broader market.

Summary

Cabot beats Innospec on 15 of the 19 factors compared between the two stocks.

How does Cabot compare to AdvanSix?

Cabot (NYSE:CBT) and AdvanSix (NYSE:ASIX) are both basic materials companies, but which is the better business? We will contrast the two companies based on the strength of their analyst recommendations, earnings, institutional ownership, risk, dividends, media sentiment, valuation and profitability.

Cabot has a net margin of 7.97% compared to AdvanSix's net margin of 0.67%. Cabot's return on equity of 21.33% beat AdvanSix's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Cabot	7.97%	21.33%	9.48%
AdvanSix	0.67%	2.18%	1.05%

Cabot currently has a consensus price target of $85.80, suggesting a potential downside of 2.27%. AdvanSix has a consensus price target of $22.50, suggesting a potential upside of 7.63%. Given AdvanSix's higher possible upside, analysts plainly believe AdvanSix is more favorable than Cabot.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Cabot	1 Sell rating(s)	4 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.14
AdvanSix	1 Sell rating(s)	2 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.67

93.2% of Cabot shares are held by institutional investors. Comparatively, 86.4% of AdvanSix shares are held by institutional investors. 3.1% of Cabot shares are held by insiders. Comparatively, 5.0% of AdvanSix shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Cabot has higher revenue and earnings than AdvanSix. Cabot is trading at a lower price-to-earnings ratio than AdvanSix, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Cabot	$3.71B	1.22	$331M	$5.29	16.60
AdvanSix	$1.52B	0.37	$49.29M	$0.37	56.50

In the previous week, Cabot had 1 more articles in the media than AdvanSix. MarketBeat recorded 4 mentions for Cabot and 3 mentions for AdvanSix. AdvanSix's average media sentiment score of 0.75 beat Cabot's score of 0.57 indicating that AdvanSix is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Cabot	0 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
AdvanSix	1 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Cabot pays an annual dividend of $1.89 per share and has a dividend yield of 2.2%. AdvanSix pays an annual dividend of $0.64 per share and has a dividend yield of 3.1%. Cabot pays out 35.7% of its earnings in the form of a dividend. AdvanSix pays out 173.0% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Cabot has increased its dividend for 14 consecutive years and AdvanSix has increased its dividend for 2 consecutive years.

Cabot has a beta of 0.83, indicating that its share price is 17% less volatile than the broader market. Comparatively, AdvanSix has a beta of 1.3, indicating that its share price is 30% more volatile than the broader market.

Summary

Cabot beats AdvanSix on 13 of the 19 factors compared between the two stocks.

How does Cabot compare to Avient?

Avient (NYSE:AVNT) and Cabot (NYSE:CBT) are both mid-cap basic materials companies, but which is the better investment? We will compare the two businesses based on the strength of their earnings, risk, media sentiment, analyst recommendations, institutional ownership, dividends, valuation and profitability.

Avient currently has a consensus price target of $45.71, suggesting a potential upside of 28.39%. Cabot has a consensus price target of $85.80, suggesting a potential downside of 2.27%. Given Avient's stronger consensus rating and higher possible upside, research analysts plainly believe Avient is more favorable than Cabot.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Avient	0 Sell rating(s)	4 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.43
Cabot	1 Sell rating(s)	4 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.14

95.5% of Avient shares are owned by institutional investors. Comparatively, 93.2% of Cabot shares are owned by institutional investors. 0.9% of Avient shares are owned by company insiders. Comparatively, 3.1% of Cabot shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Avient has a beta of 1.27, meaning that its share price is 27% more volatile than the broader market. Comparatively, Cabot has a beta of 0.83, meaning that its share price is 17% less volatile than the broader market.

Avient pays an annual dividend of $1.10 per share and has a dividend yield of 3.1%. Cabot pays an annual dividend of $1.89 per share and has a dividend yield of 2.2%. Avient pays out 64.0% of its earnings in the form of a dividend. Cabot pays out 35.7% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Avient has raised its dividend for 1 consecutive years and Cabot has raised its dividend for 14 consecutive years.

Cabot has a net margin of 7.97% compared to Avient's net margin of 4.81%. Cabot's return on equity of 21.33% beat Avient's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Avient	4.81%	11.11%	4.40%
Cabot	7.97%	21.33%	9.48%

In the previous week, Cabot had 1 more articles in the media than Avient. MarketBeat recorded 4 mentions for Cabot and 3 mentions for Avient. Avient's average media sentiment score of 0.78 beat Cabot's score of 0.57 indicating that Avient is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Avient	1 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Cabot	0 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Cabot has higher revenue and earnings than Avient. Cabot is trading at a lower price-to-earnings ratio than Avient, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Avient	$3.26B	1.00	$81.90M	$1.72	20.70
Cabot	$3.71B	1.22	$331M	$5.29	16.60

Summary

Cabot beats Avient on 11 of the 19 factors compared between the two stocks.

How does Cabot compare to Chemours?

Cabot (NYSE:CBT) and Chemours (NYSE:CC) are both mid-cap basic materials companies, but which is the better investment? We will compare the two companies based on the strength of their media sentiment, risk, earnings, institutional ownership, dividends, analyst recommendations, valuation and profitability.

Cabot has higher earnings, but lower revenue than Chemours. Chemours is trading at a lower price-to-earnings ratio than Cabot, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Cabot	$3.71B	1.22	$331M	$5.29	16.60
Chemours	$5.81B	0.47	-$386M	-$2.64	N/A

Cabot has a beta of 0.83, suggesting that its share price is 17% less volatile than the broader market. Comparatively, Chemours has a beta of 1.41, suggesting that its share price is 41% more volatile than the broader market.

Cabot currently has a consensus price target of $85.80, suggesting a potential downside of 2.27%. Chemours has a consensus price target of $24.10, suggesting a potential upside of 33.02%. Given Chemours' stronger consensus rating and higher probable upside, analysts plainly believe Chemours is more favorable than Cabot.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Cabot	1 Sell rating(s)	4 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.14
Chemours	1 Sell rating(s)	5 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.42

93.2% of Cabot shares are owned by institutional investors. Comparatively, 76.3% of Chemours shares are owned by institutional investors. 3.1% of Cabot shares are owned by insiders. Comparatively, 0.9% of Chemours shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

In the previous week, Cabot and Cabot both had 4 articles in the media. Chemours' average media sentiment score of 1.06 beat Cabot's score of 0.57 indicating that Chemours is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Cabot	0 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Chemours	3 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Cabot has a net margin of 7.97% compared to Chemours' net margin of -6.82%. Chemours' return on equity of 52.49% beat Cabot's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Cabot	7.97%	21.33%	9.48%
Chemours	-6.82%	52.49%	1.78%

Cabot pays an annual dividend of $1.89 per share and has a dividend yield of 2.2%. Chemours pays an annual dividend of $0.35 per share and has a dividend yield of 1.9%. Cabot pays out 35.7% of its earnings in the form of a dividend. Chemours pays out -13.3% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Cabot has raised its dividend for 14 consecutive years. Cabot is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.

Summary

Cabot beats Chemours on 10 of the 18 factors compared between the two stocks.

How does Cabot compare to Eastman Chemical?

Cabot (NYSE:CBT) and Eastman Chemical (NYSE:EMN) are both mid-cap basic materials companies, but which is the better stock? We will compare the two companies based on the strength of their dividends, institutional ownership, risk, profitability, media sentiment, valuation, analyst recommendations and earnings.

93.2% of Cabot shares are owned by institutional investors. Comparatively, 83.7% of Eastman Chemical shares are owned by institutional investors. 3.1% of Cabot shares are owned by company insiders. Comparatively, 2.6% of Eastman Chemical shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Cabot has a beta of 0.83, indicating that its share price is 17% less volatile than the broader market. Comparatively, Eastman Chemical has a beta of 1.07, indicating that its share price is 7% more volatile than the broader market.

In the previous week, Cabot had 2 more articles in the media than Eastman Chemical. MarketBeat recorded 4 mentions for Cabot and 2 mentions for Eastman Chemical. Cabot's average media sentiment score of 0.57 beat Eastman Chemical's score of 0.56 indicating that Cabot is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Cabot	0 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Eastman Chemical	1 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Cabot pays an annual dividend of $1.89 per share and has a dividend yield of 2.2%. Eastman Chemical pays an annual dividend of $3.36 per share and has a dividend yield of 5.0%. Cabot pays out 35.7% of its earnings in the form of a dividend. Eastman Chemical pays out 97.4% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Cabot has increased its dividend for 14 consecutive years and Eastman Chemical has increased its dividend for 15 consecutive years. Eastman Chemical is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.

Cabot presently has a consensus price target of $85.80, indicating a potential downside of 2.27%. Eastman Chemical has a consensus price target of $79.67, indicating a potential upside of 18.65%. Given Eastman Chemical's stronger consensus rating and higher possible upside, analysts plainly believe Eastman Chemical is more favorable than Cabot.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Cabot	1 Sell rating(s)	4 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.14
Eastman Chemical	0 Sell rating(s)	7 Hold rating(s)	7 Buy rating(s)	0 Strong Buy rating(s)	2.50

Eastman Chemical has higher revenue and earnings than Cabot. Cabot is trading at a lower price-to-earnings ratio than Eastman Chemical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Cabot	$3.71B	1.22	$331M	$5.29	16.60
Eastman Chemical	$8.75B	0.88	$474M	$3.45	19.46

Cabot has a net margin of 7.97% compared to Eastman Chemical's net margin of 4.62%. Cabot's return on equity of 21.33% beat Eastman Chemical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Cabot	7.97%	21.33%	9.48%
Eastman Chemical	4.62%	8.88%	3.52%

Summary

Cabot beats Eastman Chemical on 10 of the 19 factors compared between the two stocks.

Get Cabot News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding CBT and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

CBT vs. The Competition

Export

Metric	Cabot	CHEM Industry	Materials Sector	NYSE Exchange
Market Cap	$4.51B	$13.26B	$4.58B	$23.46B
Dividend Yield	2.16%	2.62%	5.03%	4.02%
P/E Ratio	16.60	35.65	20.24	28.30
Price / Sales	1.22	1.76	5,824.19	19.75
Price / Cash	8.40	11.85	24.17	18.64
Price / Book	2.74	1.89	8.68	4.77
Net Income	$331M	$171.68M	$157.11M	$1.06B
7 Day Performance	0.16%	0.47%	-2.62%	-0.56%
1 Month Performance	0.18%	-5.63%	-4.45%	-0.11%
1 Year Performance	11.95%	21.17%	37.38%	16.64%

Cabot Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
CBT Cabot	3.4197 of 5 stars	$87.79 +0.5%	$85.80 -2.3%	+11.4%	$4.51B	$3.71B	16.60	4,100	Dividend Announcement
IOSP Innospec	3.1876 of 5 stars	$80.71 -2.3%	N/A	-7.5%	$2.04B	$1.78B	17.58	2,450
ASIX AdvanSix	3.1071 of 5 stars	$19.72 -2.7%	$22.50 +14.1%	-11.8%	$546.46M	$1.52B	53.29	1,410	News Coverage
AVNT Avient	4.4864 of 5 stars	$36.79 -2.9%	$45.71 +24.2%	+5.5%	$3.48B	$3.28B	21.39	9,000
CC Chemours	4.3899 of 5 stars	$20.04 -3.4%	$24.60 +22.8%	+29.0%	$3.12B	$5.81B	N/A	5,700

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NYSE:CBT) was last updated on 7/13/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Cabot (CBT) Competitors